−0.250 SEK
−4.74 M SEK
17.50 M SEK
11.13 M
About INHALATION SCIENCES SWEDEN AB
Sector
Industry
CEO
Manoush Masarrat
Website
Headquarters
Huddinge
Founded
2004
ISIN
SE0009983893
FIGI
BBG00HL45RZ7
Inhalation Sciences Sweden AB develops and sells patented, labtech equipment for inhalation research. Its products include PreciseInhale, which is an advanced laboratory system that lets scientists measure how inhaled particles act in lungs and affect health; LaminarPace which is a patented tool for drying small amounts of drug substance with very low levels of wastage. The company was founded by Per Magnus Gerde in 2005 and is headquartered in Huddinge, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ISAB is 1.790 SEK — it has increased by 2.91% in the past 24 hours. Watch INHALATION SCIENCES SWEDEN AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NGM exchange INHALATION SCIENCES SWEDEN AB stocks are traded under the ticker ISAB.
ISAB stock has risen by 4.42% compared to the previous week, the month change is a 9.26% rise, over the last year INHALATION SCIENCES SWEDEN AB has showed a −57.98% decrease.
ISAB reached its all-time high on May 7, 2020 with the price of 14.550 SEK, and its all-time low was 1.205 SEK and was reached on Dec 9, 2024. View more price dynamics on ISAB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ISAB stock is 13.12% volatile and has beta coefficient of 0.38. Track INHALATION SCIENCES SWEDEN AB stock price on the chart and check out the list of the most volatile stocks — is INHALATION SCIENCES SWEDEN AB there?
Today INHALATION SCIENCES SWEDEN AB has the market capitalization of 26.85 M, it has increased by 13.16% over the last week.
Yes, you can track INHALATION SCIENCES SWEDEN AB financials in yearly and quarterly reports right on TradingView.
ISAB net income for the last quarter is −1.02 M SEK, while the quarter before that showed −918.00 K SEK of net income which accounts for −10.89% change. Track more INHALATION SCIENCES SWEDEN AB financial stats to get the full picture.
No, ISAB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INHALATION SCIENCES SWEDEN AB EBITDA is −2.50 M SEK, and current EBITDA margin is −23.14%. See more stats in INHALATION SCIENCES SWEDEN AB financial statements.
Like other stocks, ISAB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INHALATION SCIENCES SWEDEN AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INHALATION SCIENCES SWEDEN AB technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INHALATION SCIENCES SWEDEN AB stock shows the sell signal. See more of INHALATION SCIENCES SWEDEN AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.